These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38646637)

  • 41. Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.
    Nampota-Nkomba N; Nyirenda OM; Khonde L; Mapemba V; Mbewe M; Ndaferankhande JM; Msuku H; Masesa C; Misiri T; Mwakiseghile F; Patel PD; Patel P; Johnson-Mayo I; Pasetti MF; Heyderman RS; Tracy JK; Datta S; Liang Y; Neuzil KM; Gordon MA; Laurens MB;
    Lancet Glob Health; 2022 Sep; 10(9):e1326-e1335. PubMed ID: 35961356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
    Nolan T; Booy R; Marshall HS; Richmond P; Nissen M; Ziegler JB; Baine Y; Traskine M; Jastorff A; Van der Wielen M
    Pediatr Infect Dis J; 2019 Jun; 38(6):643-650. PubMed ID: 31116180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccines for preventing typhoid fever.
    Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
    Zambrano B; Peterson J; Deseda C; Julien K; Spiegel CA; Seyler C; Simon M; Hoki R; Anderson M; Brabec B; Áñez G; Shi J; Pan J; Hagenbach A; Von Barbier D; Varghese K; Jordanov E; Dhingra MS
    Pediatr Res; 2023 Sep; 94(3):1035-1043. PubMed ID: 36899125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.
    Gajdos V; Soubeyrand B; Vidor E; Richard P; Boyer J; Sadorge C; Fiquet A
    Hum Vaccin; 2011 May; 7(5):549-56. PubMed ID: 21441781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh.
    Khanam F; Babu G; Rahman N; Liu X; Rajib NH; Ahmed SU; Hossen MI; Biswas PK; Kelly S; Thesis-Nyland K; Mujadidi Y; McMillan NAJ; Pollard AJ; Clemens JD; Qadri F
    Vaccine; 2023 May; 41(19):3137-3140. PubMed ID: 37061369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.
    Sirima SB; Ouedraogo A; Barry N; Siribie M; Tiono A; Nébié I; Konaté A; Berges GD; Diarra A; Ouedraogo M; Bougouma EC; Soulama I; Hema A; Datta S; Liang Y; Rotrosen ET; Tracy JK; Jamka LP; Oshinsky JJ; Pasetti MF; Neuzil KM; Laurens MB
    Int J Infect Dis; 2021 Jul; 108():465-472. PubMed ID: 34082090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.
    Cui C; Carbis R; An SJ; Jang H; Czerkinsky C; Szu SC; Clemens JD
    Clin Vaccine Immunol; 2010 Jan; 17(1):73-9. PubMed ID: 19889941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Laurens MB; Sirima SB; Rotrosen ET; Siribie M; Tiono A; Ouedraogo A; Liang Y; Jamka LP; Kotloff KL; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S59-S66. PubMed ID: 30845330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Theiss-Nyland K; Shakya M; Colin-Jones R; Voysey M; Smith N; Karkey A; Dongol S; Pant D; Farooq YG; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S67-S73. PubMed ID: 30845329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgA and IgG1 Specific to Vi Polysaccharide of
    Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
    Front Immunol; 2019; 10():2582. PubMed ID: 31781100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.
    Thiem VD; Lin FY; Canh DG; Son NH; Anh DD; Mao ND; Chu C; Hunt SW; Robbins JB; Schneerson R; Szu SC
    Clin Vaccine Immunol; 2011 May; 18(5):730-5. PubMed ID: 21411598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled trial [corrected] administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women.
    Salama MM; Hady OA; Ashour W; Mostafa A; El Alkamy S; El Sayed N; El Yazeed RA
    J Clin Immunol; 2009 Jul; 29(4):524-31. PubMed ID: 19363703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT).
    Lee EY; Park JY; Kim DR; Song M; Sahastrabuddhe S; Kim H; Chon Y; Yang JS
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008171. PubMed ID: 32203521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Typhoid Conjugate Vaccine: A Boon for Endemic Regions.
    Agarwal N; Gupta N; Nishant ; H S S; Dutta T; Mahajan M
    Cureus; 2024 Mar; 16(3):e56454. PubMed ID: 38650789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine.
    Szu SC; Lin KF; Hunt S; Chu C; Thinh ND
    Vaccine; 2014 May; 32(22):2618-22. PubMed ID: 24657719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
    Shakya M; Colin-Jones R; Theiss-Nyland K; Voysey M; Pant D; Smith N; Liu X; Tonks S; Mazur O; Farooq YG; Clarke J; Hill J; Adhikari A; Dongol S; Karkey A; Bajracharya B; Kelly S; Gurung M; Baker S; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ;
    N Engl J Med; 2019 Dec; 381(23):2209-2218. PubMed ID: 31800986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis.
    Khanam F; Kim DR; Liu X; Voysey M; Pitzer VE; Zaman K; Pollard AJ; Qadri F; Clemens JD
    EClinicalMedicine; 2023 Apr; 58():101925. PubMed ID: 37090439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
    Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
    Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.